We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Advises Virtual Ban On Amgen, J&J Anemia Drugs

Law360 (March 13, 2008, 12:00 AM EDT) -- A U.S. Food and Drug Administration panel reportedly voted Thursday to ban the use of anemia drugs, including Amgen Inc.'s Aranesp and Epogen and Johnson & Johnson's Procrit, in most cancer...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.